000 05589nam a22004215i 4500
999 _c6168
_d6168
001 6168
003 ES-MaUEC
005 20201203160809.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191001s2020 gw | s |||| 0|eng d
020 _a9783030232351
024 7 _a10.1007/978-3-030-23235-1
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRG201
_b.D56 2020 EB
245 0 0 _aDiminished Ovarian Reserve and Assisted Reproductive Technologies
_bCurrent Research and Clinical Management
_cedited by Orhan Bukulmez.
250 _a1st ed. 2020.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2020.
300 _a1 recurso en línea (XX, 360 páginas)
_b47 ilustraciones, 31 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aPart I: The paradigm of diminished ovarian reserve, conventional & adjuvant treatment approaches for assisted reproductive technologies. 1. Introduction: The Scope of the Problem of Diminished Ovarian Reserve -- 2. Ovarian and Hypothalamic Aging -- 3. Natural History of Diminished Ovarian Reserve -- 4. Definitions and Relevance: Diminished Ovarian Reserve, Poor Ovarian Response, Advanced Reproductive Age, Premature Ovarian Insufficiency -- 5. Food Supplements and Hormonal Products to Improve Assisted Reproductive Technology Outcomes in Diminished Ovarian Reserve Patients -- 6. Traditional Chinese Medicine for Assisted Reproductive Technology -- 7. Controlled Ovarian Stimulation Protocols for IVF: From First IVF baby in the United States and Beyond -- 8. Conventional Controlled Ovarian Stimulation Protocols for Diminished Ovarian Reserve Patients and Poor Responders -- 9. Natural Cycle Approaches for ART -- Part II: Minimal and Mild Stimulation Protocols -- 10. The International Society for Mild Approaches in Assisted Reproduction (ISMAAR) Definitions for Mild Stimulation and Their Rationale for Assisted Reproductive Technologies -- 11. Current Outlook of Minimal and Mild Stimulation Protocols for Assisted Reproductive Technologies in Women with Diminished Ovarian Reserve and/or Advanced Reproductive Age -- 12. Minimal Stimulation Protocol for Assisted Reproductive Technologies in Women with Diminished Ovarian Reserve and/or Advanced Reproductive Age -- 13. Mild Stimulation Alternatives to Minimal Stimulation -- 14. Control of Luteinizing Hormone (LH) -- 15. Preventing Premature Ovulation -- 16. Trigger Agents and Post-trigger Testing -- 17. Oocyte retrieval -- 18. Fertilization: Conventional IVF versus ICSI -- 19. Embryo Culture: Cleavage versus Blastocyst Stage -- 20. Endometrial Considerations for Minimal Stimulation -- 21. Frozen Embryo Transfer Preparation -- 22. Minimal and Mild Stimulation IVF Results -- Part III: Utilization of Contemporary Technologies in Diminished Ovarian Reserve Patients -- 23. Fresh versus Frozen Embryo Transfer -- 24. Comprehensive Chromosome Analysis in Diminished Ovarian Reserve Patients -- Part IV: Future Prospects -- 25. Artificial Oocyte and Artificial Ovary Development -- 26. Activation of Ovarian Cortex -- 27. Oocyte Freezing at an Earlier Age -- 28. Ovarian Cortical Tissue Biopsy for Freezing and Auto Transplantation.
520 _aThis book brings together the most current research and the latest clinical approaches to the management of diminished ovarian reserve (DOR), one of the largest segments of the IVF patient population, both in the advanced reproductive age group as well as poor responders. Opening with a review of the definition and scope of the problem, as well as the current understanding of the natural history of DOR, subsequent chapters in part I outline dietary, hormonal, traditional supplements and conventional methods used to stimulate ovaries and improve ART outcomes. The main segment of chapters, comprising part II, present minimal and mild stimulation protocols and alternatives, frozen embryo transfer preparation, trigger agents and post-trigger testing, embryo culture and endometrial considerations, and a review of clinical outcomes. Part III discusses the utilization of contemporary technologies in the treatment of DOR, including fresh vs. frozen embryo transfer, cryopreservation and comprehensive chromosomal analysis. Future prospects are presented in part IV, such as the artificial oocyte and ovary development, early-age oocyte freezing, ovarian cortical tissue freezing and activation of the ovarian cortex. Utilizing the latest evidence and authored by an international array of thought leaders, Diminished Ovarian Reserve and Assisted Reproductive Technologies is an excellent resource for reproductive medicine and REI specialists, IVF lab professionals, and students and residents in these areas.
988 _aSegundosemestre_2019_Medicine
650 7 _9140533
_aEsterilidad
700 1 _aBukulmez, Orhan
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783030232344
776 0 8 _iPrinted edition:
_z9783030232368
776 0 8 _iPrinted edition:
_z9783030232375
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-23235-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_zSI